Editorial comment - Risk stratification in hypertrophic cardiomyopathy - Fact or fiction?

被引:15
作者
Hess, OM [1 ]
机构
[1] Univ Hosp, Swiss Cardiovasc Ctr, Bern, Switzerland
关键词
D O I
10.1016/S0735-1097(03)00838-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:880 / 881
页数:2
相关论文
共 7 条
[1]   Genomic circuits and the integrative biology of cardiomyopathies [J].
Chien, KR .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) :L3-L9
[2]   Arrhythmia substrate and management in hypertrophic cardiomyopathy: from molecules to implantable cardioverter-defibrillators [J].
Janse, MJ ;
De Bakker, JMT .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) :L15-L20
[3]   Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. [J].
Maron, BJ ;
Shen, WK ;
Link, MS ;
Epstein, AE ;
Almquist, AK ;
Daubert, JP ;
Bardy, GH ;
Favale, S ;
Rea, RF ;
Boriani, G ;
Estes, NAM ;
Spirito, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (06) :365-373
[4]   Hypertrophic cardiomyopathy: management, risk stratification, and prevention of sudden death [J].
McKenna, WJ ;
Behr, ER .
HEART, 2002, 87 (02) :169-176
[5]   Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: An independent marker of sudden death risk in young patients [J].
Monserrat, L ;
Elliott, PM ;
Gimeno, JR ;
Sharma, S ;
Penas-Lado, M ;
McKenna, WJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) :873-879
[6]   RISK STRATIFICATION IN HYPERTROPHIC CARDIOMYOPATHY [J].
VASSALLI, G ;
SEILER, C ;
HESS, OM .
CURRENT OPINION IN CARDIOLOGY, 1994, 9 (03) :330-336
[7]  
Watkins H, 2001, EUR HEART J SUPPL, V3, pL43, DOI 10.1016/S1520-765X(01)90064-1